FindMyKOL
Clinical trialNCT01685372CompletedPhase 2Interventional

Immunogenicity of Fluzone High Dose in Immunocompromised Children and Young Adults

SponsorUniversity of Colorado, DenverEnrollment16Bone Marrow Transplant (BMT)DialysisHuman Immunodeficiency Virus (HIV)Rheumatologic DisorderSolid Organ Transplant Recipient (Liver, Kidney, Heart)
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to determine whether Fluzone High Dose increases the immune response to the influenza antigens contained in the vaccine compared to standard-dose Fluzone in immunocompromised children and young adults. Safety and efficacy data will also be collected.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

  • Donna Curtis, MD, MPH

    Children's Hospital Colorado, University of Colorado Denver School of Medicine

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Children'S Hospital Colorado

    Aurora, Colorado, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Sept 2012
Primary completion
30 Sept 2015
Completion
30 Sept 2017
Last update posted
23 Jan 2018
Registered enrollment
16
Registry id
NCT01685372

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.